Dan Li
Impact in
- Biological Psychiatry top 2%
- Immunology top 1%
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- Epigenetics and DNA Methylation 18
- Natural product bioactivities and synthesis 16
- Immunology 72
- Immune cells in cancer 20
- Immune Cell Function and Interaction 20
- Co-authors
- Yongsheng Wang (4 shared papers)Cheng Peng (18 shared papers)Qizhi Ma (2 shared papers)Benxia Zhang (2 shared papers)Ligen Lin (15 shared papers)Houhui Shi (1 shared paper)Pei Shu (1 shared paper)Kai Li (1 shared paper)
- Journals
- Frontiers in Immunology (14 papers)Frontiers in Pharmacology (9 papers)Phytomedicine (7 papers)Toxicology and Applied Pharmacology (6 papers)Oncotarget (5 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Dan Li
384 papers receiving 9.7k citations
Dan Li's Hit Papers
Peers
Comparison fields: 5 of 167
- Biological Psychiatry 199
- Immunology 1.7k
- Geriatrics and Gerontology 219
- Biochemistry 403
- Neurology 486
Countries citing papers authored by Dan Li
This map shows the geographic impact of Dan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Li more than expected).
Fields of papers citing papers by Dan Li
This network shows the impact of papers produced by Dan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Li. The network helps show where Dan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 397 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer Hit paper breakdown → | 2021 | 653 |
| 2 | Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives Hit paper breakdown → | 2021 | 363 |
| 3 | 2017 | 247 | |
| 4 | A small molecule HIF-1α stabilizer that accelerates diabetic wound healing Hit paper breakdown → | 2021 | 199 |
| 5 | 2014 | 189 | |
| 6 | 2008 | 170 | |
| 7 | 2020 | 159 | |
| 8 | 2008 | 144 | |
| 9 | 2016 | 136 | |
| 10 | 2017 | 132 | |
| 11 | 2013 | 131 | |
| 12 | 2018 | 108 | |
| 13 | 2010 | 105 | |
| 14 | 2009 | 105 | |
| 15 | 2009 | 91 | |
| 16 | 2016 | 85 | |
| 17 | 2018 | 85 | |
| 18 | 2022 | 82 | |
| 19 | 2011 | 81 | |
| 20 | 2022 | 79 |
About Dan Li
Dan Li is a scholar working on Molecular Biology, Immunology, Epidemiology, Neurology and Oncology, having authored 397 papers that have together received 9.8k indexed citations. Recurring topics across this work include Bone Tissue Engineering Materials (21 papers), Immune cells in cancer (20 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers), Immune Cell Function and Interaction (20 papers), Epigenetics and DNA Methylation (18 papers), Natural product bioactivities and synthesis (16 papers), Autophagy in Disease and Therapy (13 papers) and Cancer, Hypoxia, and Metabolism (13 papers). The work is most often cited by research in Biological Psychiatry (199 citations), Immunology (1.7k citations), Geriatrics and Gerontology (219 citations), Biochemistry (403 citations) and Neurology (486 citations). Dan Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Yongsheng Wang, Cheng Peng, Qizhi Ma, Benxia Zhang, Ligen Lin, Houhui Shi, Pei Shu, Kai Li, Yue Chen and Xuejin Ou. Their work appears in journals such as Frontiers in Immunology, Frontiers in Pharmacology, Phytomedicine, Toxicology and Applied Pharmacology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.